{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Elisidepsin",
  "nciThesaurus": {
    "casRegistry": "681272-30-0",
    "chebiId": "",
    "chemicalFormula": "C57H87N7O15",
    "definition": "A synthetic cyclic depsipeptide of the kahalalides family with potential antineoplastic activity. PM02734 is a derivative of a natural marine compound extracted from the sacoglossan sea slug, Elysia rufescens. Although the exact mechanism of action has yet to be elucidated, elisidepsin exhibits anti-proliferative activity in a wide variety of cancer types, such as breast, colon, pancreas, lung, and prostate.",
    "fdaUniiCode": "0FWR494EC9",
    "identifier": "C66949",
    "preferredName": "Elisidepsin",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1976"
    ],
    "synonyms": [
      "Depsipeptide PM02734",
      "ELISIDEPSIN",
      "Elisidepsin",
      "L-Valine, N-((4S)-4-methyl-1-oxohexyl)-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-amino-2-butenoyl-, (13-8)-lactone, 2,2,2-trifluoroacetate (1:1)",
      "PM02734"
    ]
  }
}